The CDC anticipates having adequate supply and shouldn’t need to prioritize certain groups, like the elderly or immunocompromised, for first doses, officials said at a Tuesday committee meeting. Read More
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.